BRODALUMAB for Product use in unapproved indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where BRODALUMAB was used for Product use in unapproved indication.
Most Reported Side Effects for BRODALUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Psoriasis | 418 | 20.1% | 8 | 133 |
| Drug ineffective | 177 | 8.5% | 2 | 39 |
| Arthralgia | 175 | 8.4% | 3 | 37 |
| Fatigue | 152 | 7.3% | 4 | 31 |
| Psoriatic arthropathy | 141 | 6.8% | 2 | 18 |
| Intentional product use issue | 136 | 6.5% | 7 | 40 |
| Headache | 126 | 6.1% | 4 | 30 |
| Therapy interrupted | 126 | 6.1% | 6 | 44 |
| Product dose omission issue | 124 | 6.0% | 7 | 57 |
| Disease recurrence | 118 | 5.7% | 4 | 31 |
| Inappropriate schedule of product administration | 108 | 5.2% | 1 | 36 |
| Off label use | 99 | 4.8% | 2 | 34 |
| Diarrhoea | 92 | 4.4% | 1 | 26 |
| Therapy cessation | 89 | 4.3% | 2 | 24 |
| Covid-19 | 82 | 3.9% | 5 | 29 |
Other Indications for BRODALUMAB
Psoriasis (1,595)
Product used for unknown indication (284)
Psoriatic arthropathy (107)
Pustular psoriasis (39)
Hidradenitis (24)
Erythrodermic psoriasis (17)
Chronic spontaneous urticaria (9)
Palmoplantar pustulosis (8)
Ankylosing spondylitis (6)
Axial spondyloarthritis (5)
Other Drugs Used for Product use in unapproved indication
RIFAXIMIN (421)
ABOBOTULINUMTOXINA (334)
HYDROXYCHLOROQUINE (212)
PRABOTULINUMTOXINA-XVFS (152)
LOTEPREDNOL ETABONATE (114)
DEXAMETHASONE (105)
DICLOFENAC (89)
OBETICHOLIC ACID (87)
BRIMONIDINE (79)
DUPILUMAB (74)